Subscribe to Search results

Nicholas Calder was swapped from cryoprecipitate to factor VIII concentrate. His mother did not consent to the change and was never informed of the viral risk in the blood product. Nicholas was mostly treated with NHS concentrate but received commercial products several times.

Published on:

Rosemary Calder sought advice from Dr Cecil Reid about AIDS and was told to carry on with her son's home treatment as normal because the risk of contracting an infection was minimal.

Published on:

Ms Calder did not consent to a HIV test which confirmed her son was HIV positive at 11 years old. They were informed by a letter in the post.

Published on:

A young man with mild Haemophilia B underwent a non-vital operation in 1984 to remove a birthmark, following which he received treatment with Factor 9 concentrate which infected him with Hepatitis C, when it was known that factor replacement therapy was potentially both HIV and Hepatitis C infectious. At no stage was any cautionary information given. He only learned that he had Hepatitis C in 1999.

Published on:

In a letter Professor Bloom outlined all factor concentrate carried the risk of hepatitis, particularly non-A, non-B, and this was something that haemophiliacs would have to accept.

Published on:

A man with mild haemophilia, given concentrate as part of training sessions in 1982 at the Royal Liverpool Hospital as a child, explained that his family was "told Factor VIII was safer, less bulky, easier to store and easier to use than Cryoprecipitate." He discovered he was Hepatitis C positive only in 1994 when attending a standard review at the Haemophilia Centre, not having been told that he was being tested.

Published on:

A boy whose care was reviewed at Oxford was switched from cryoprecipitate to concentrates in 1976. Dr Rizza wrote to his referring haemophilia clinician advising to treat him with the N.H.S. concentrates and as a last resort it may be justified to put him onto one of the commercial Factor VIII concentrates. The reason for that recommendation was not specified and his parents were never told of any risk of infection associated with the use of factor concentrates.

Published on:

An individual who was unaware that his blood was tested for HIV received a letter from Dr Theodore Blecher referring to the results on recent blood samples and requesting for a meeting to discuss the results

Published on:

A patient recalled in their witness statement to the inquiry that he was told that Factor VIII was safer, less bulky, easier to store and easier to use than Cryoprecipitate. His parents were assured that if he were to contract hepatitis it would be no more severe than a bad cold.

Published on:

A witness with mild Haemophilia B was first given Factor 9 concentrate dental treatment at Royal Stoke Hospital. She did not know she was being given a blood product and was not told about any risks of infection.

Published on:

A witness with mild Haemophilia B was given Factor 9 concentrate in 1980 for dental treatment at Royal Stoke Hospital. She did not know she was being given a blood product and was not told about any risks of infection.

Published on:

A witness was treated treatment with Factor 9 concentrates. She had said she did not want to receive it because of the fear of HIV but she was given it whilst drowsy from pre-med and felt that she was not given a real choice.

Published on:

A patient recalled in his witness statement to the inquiry that he had never been told of any associated risks when he was first given Factor VIII in 1983 or 1984 at the Royal Hallamshire Hospital

Published on:

Inquiry issues letter about compensation

Published on:

Inquiry round-up

Published on:

Inquiry receives letter from the Paymaster General

Published on:

In 1981 and 1982 Haemophilia A patients were primarily treated at the Royal Manchester Childrens' Hospital with commercial concentrate and no NHS concentrate was used at all.

Published on:

By September 1982, Cryoprecipitate tended to be used for hospital treatment and concentrates for home treatment at the Royal Manchester Childrens' Hospital .

Published on:

At the Royal Manchester Children's Hospital, parents were unaware that their children were being tested for HIV.

Published on:

Annual returns showed that there was no policy of restricting patients to single manufacturers or batches of commercial concentrate.

Published on: